Back to trial details

Intake questionnaire

ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab

Applying to MD Anderson in The Woodlands · Conroe, Texas

This location is no longer enrolling.

Other locations for this study may still be open.

Pick another location